Familial hypercholesterolemia is a genetic condition that causes very high LDL cholesterol from birth. People with familial hypercholesterolemia often have no symptoms at first, but doctors may see cholesterol deposits on tendons or around the eyes. The condition lasts lifelong and raises the risk of early heart disease and heart attack. It affects children and adults, and severity can vary by whether one or both gene copies are affected. Treatment focuses on lowering LDL with statins, ezetimibe, PCSK9 inhibitors, and lifestyle changes, and this can reduce complications and improve life expectancy.
Overview
Familial hypercholesterolemiaSymptoms
Familial hypercholesterolemia often has no symptoms until early heart problems, like chest pain or shortness of breath with exertion. Features doctors may notice include high LDL cholesterol, tendon or eyelid fatty bumps, and a gray corneal ring, sometimes from childhood.
Outlook and prognosis
Many people with familial hypercholesterolemia live long, active lives with early diagnosis and consistent treatment. Lowering LDL cholesterol sharply reduces heart attack and stroke risk. Regular checkups, heart-healthy habits, and medicines—or lipoprotein apheresis for some—support a strong long‑term outlook.
Causes and risk factors
Familial hypercholesterolemia results from inherited gene changes, commonly LDLR, APOB, or PCSK9. One altered copy raises risk; two cause more severe illness. Family history, ancestry, and factors like high saturated fat intake, smoking, age, and obesity can worsen cholesterol.
Genetic influences
Genetics are central in familial hypercholesterolemia: most cases result from inherited variants that raise LDL cholesterol from birth. A single altered gene can markedly increase lifelong heart risk. Family screening helps identify relatives who may also be affected.
Diagnosis
Doctors diagnose Familial hypercholesterolemia using clinical features—very high LDL cholesterol, early heart disease in family, or tendon lumps—supported by lipid tests. Genetic tests can confirm the genetic diagnosis of Familial hypercholesterolemia. Cascade testing of relatives helps identify affected family members.
Treatment and drugs
Familial hypercholesterolemia treatment focuses on lowering LDL cholesterol early and steadily to protect the heart. Many start with high-intensity statins, often combined with ezetimibe; some add PCSK9 or siRNA injectables, or bile-acid medicines. Lifestyle measures and family screening support long-term care.
Symptoms
Familial hypercholesterolemia often has no obvious signs day to day, but cholesterol levels are very high from early in life. Some people develop small fatty bumps on tendons or eyelids, or a gray ring at the edge of the iris. Early features of familial hypercholesterolemia can also show up as heart-related symptoms years earlier than expected in the family. A healthcare professional can help sort out what’s typical aging and what warrants a closer look.
LDL cholesterol is very high from a young age, often above 190 mg/dL (4.9 mmol/L) in adults and 160 mg/dL (4.1 mmol/L) in children. This is usually found on a routine blood test. Levels tend to run in families.
Small, firm, fatty bumps can develop over the Achilles tendon, elbows, knees, or fingers. Clinicians call these xanthomas, which means fatty deposits in tendons or skin. They can be tender or limit movement if large.
Yellowish patches on or near the eyelids may appear in teens or adults. These cholesterol-rich spots can occur with familial hypercholesterolemia. They are harmless but can be bothersome in appearance.
A gray or white ring around the colored part of the eye can show up early, especially before age 45. This ring forms from cholesterol at the edge of the cornea. When seen at a young age, it may point toward familial hypercholesterolemia.
How people usually first notice Familial hypercholesterolemia?
Many people first notice familial hypercholesterolemia when a routine blood test shows very high LDL cholesterol, often in childhood or early adulthood, despite a healthy lifestyle. In families with this inherited condition, doctors may spot clues like a strong history of early heart attacks or stroke, or visible features such as cholesterol deposits on the eyelids (xanthelasma), tendons (tendon xanthomas), or a pale ring around the cornea (corneal arcus) before age 45. If you’re wondering about the first signs of familial hypercholesterolemia or how familial hypercholesterolemia is first noticed, it’s often through this combination of unexpectedly high LDL levels and family history, prompting earlier screening of children and close relatives.
Types of Familial hypercholesterolemia
Familial hypercholesterolemia is a genetic condition with well-recognized variants that affect how early and how strongly high LDL cholesterol shows up. Broadly, variants are defined by which gene is involved and whether one or both copies are affected. Not everyone will experience every type. Knowing the types of familial hypercholesterolemia can help explain why some families see heart problems earlier than others.
Heterozygous FH
One altered gene copy is inherited. LDL cholesterol is usually very high from childhood, and early symptoms of familial hypercholesterolemia may be minimal until teens or adulthood. Without treatment, heart disease risk rises early, often before age 55 in men and 60 in women.
Homozygous FH
Both gene copies are altered. LDL levels are extremely high from infancy, and visible fatty deposits on tendons or around the eyes can appear in childhood. Severe artery narrowing and heart problems can occur in childhood or adolescence without aggressive treatment.
LDLR-related FH
Changes in the LDL receptor gene (LDLR) are the most common cause. Severity varies by the specific change, but LDL is typically very high and responds to standard FH treatments. Family patterns often show multiple relatives with early heart disease.
APOB-related FH
Changes in the APOB gene impair how LDL particles attach to the receptor. LDL levels are high but may be slightly lower than with some LDLR variants. Many people respond well to standard cholesterol-lowering medicines.
PCSK9-related FH
Changes in PCSK9 can raise LDL by reducing available LDL receptors. LDL is often very high, with heart risk similar to other genetic forms. Some may respond particularly well to PCSK9-targeting therapies.
Uncommon FH genes
Rare variants in genes such as LDLRAP1 (autosomal recessive hypercholesterolemia) can mimic severe FH. Symptoms can resemble homozygous FH with very early artery disease. Genetic testing helps clarify the exact variant and guide treatment.
What genetics can tell you about symptoms
In familial hypercholesterolemia, inherited changes in the LDLR, APOB, or PCSK9 genes keep “bad” LDL cholesterol high from birth, often causing no symptoms until early heart disease. Some people develop visible tendon xanthomas and yellowish eyelid plaques from cholesterol buildup.
Causes and risk factors
Familial hypercholesterolemia is caused by changes in genes such as LDLR, APOB, or PCSK9 that raise LDL cholesterol from birth.
These changes are usually inherited from a parent, but they can also appear as a new mutation.
Key risk factors for familial hypercholesterolemia include having a parent with FH and Ashkenazi Jewish or Lebanese ancestry.
In people with FH, early heart disease is more likely with smoking or an unhealthy diet, and it rises further with high blood pressure or diabetes, especially in older men.
Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Familial hypercholesterolemia usually starts before birth, so the main risks relate to biology around conception. While early symptoms of familial hypercholesterolemia can be subtle, understanding what raises the likelihood of it occurring can help with planning and screening. Doctors often group risks into internal (biological) and external (environmental). Below are factors, separate from day-to-day habits, that may nudge risk up or down.
As men get older, sperm cells go through many more rounds of copying, and small changes can arise during this process. This slightly raises the chance a child is born with a condition present from birth, and very rarely this can include familial hypercholesterolemia.
Significant radiation to the testes or ovaries before conception can increase errors when reproductive cells are formed. Everyday medical imaging uses much lower doses, but very high exposures may modestly raise the chance of conditions that start at birth.
Long-term contact with certain cell-damaging substances in the workplace, such as some heavy metals or industrial solvents, can harm reproductive cells. Regulations limit these exposures in many countries, but if present, they could slightly increase the chance of a condition that begins before birth.
Sometimes, changes arise by chance as egg or sperm cells form, without any clear outside trigger. This background chance is small but constant across families.
Genetic risk factors
Familial hypercholesterolemia (FH) is mainly driven by inherited changes in genes that control how the body clears LDL (“bad”) cholesterol from the bloodstream. These changes can be passed down in families and range from a single, high-impact variant to several smaller ones that add up. Carrying a genetic change doesn’t guarantee the condition will appear. Because early symptoms of familial hypercholesterolemia can be subtle, genetics often provides the first clear clue.
LDLR gene variants: These are the most common cause worldwide and reduce the number or function of LDL receptors. Inheritance is usually autosomal dominant, meaning one altered copy can raise LDL. The exact change influences how high LDL rises.
APOB gene variants: These alter the part of apoB that lets LDL attach to its receptor. They are typically autosomal dominant and often cause moderately high LDL. Severity can vary between families.
PCSK9 gene variants: Gain-of-function changes speed up breakdown of LDL receptors. This dominant form can produce very high LDL from a young age. Impact depends on the specific variant.
LDLRAP1 variants: Changes in this helper protein disrupt how LDL receptors pull LDL particles into the cell. Two altered copies are required, so parents may have normal cholesterol while an affected child has high LDL. This recessive form can resemble more severe FH.
Dominant inheritance: If one parent has FH from a dominant gene change, each child has a 50% (1 in 2) chance of inheriting it. All sexes are equally likely to be affected.
Two-variant FH: Inheriting harmful changes from both parents leads to very high LDL from birth. This can come from the same gene (homozygous) or two different genes (compound). It is rarer and usually more severe.
De novo variant: A new gene change can arise in someone with FH even when no relatives are known to have it. That person can still pass it to children with a 50% chance if the change is dominant. Genetic testing can confirm this.
Founder variants: In some populations, a few long-standing variants are more common due to shared ancestry. This raises the local rate of FH and clusters cases within communities. Examples include certain Dutch, Lebanese, French Canadian, and South African lineages.
Genetic modifiers: Common small-effect variants across the genome can add up and push LDL higher. They help explain why people with the same main FH variant can have different cholesterol levels. This polygenic background may shift the age when problems appear.
Family history: Multiple relatives with early heart disease or very high LDL suggest a heritable cause. Close family members may benefit from cascade genetic testing to identify the specific variant. Even without symptoms, testing can help clarify risk.
Lifestyle risk factors
Familial hypercholesterolemia (FH) is inherited, not caused by lifestyle, but daily habits still influence LDL levels, artery inflammation, and cardiovascular risk. Even small improvements can add up alongside medicines to slow plaque buildup. In other words, lifestyle risk factors for familial hypercholesterolemia can intensify the condition’s impact, while healthy choices can reduce complications and events.
Diets high in butter, fatty red meats, full-fat dairy, and fried or packaged foods raise LDL further in FH. Lowering these fats can reduce LDL by a modest amount that stacks with statins or PCSK9 inhibitors. Even modest reductions can slow plaque growth.
Sugary drinks and refined grains raise triglycerides and small dense LDL, compounding risk in FH. Choosing high‑fiber carbs helps improve lipid profile and lowers post‑meal surges that stress arteries.
Regular heavy drinking increases triglycerides and can worsen blood pressure, adding to FH-related plaque risk. If you drink, keeping intake low reduces these additive harms.
Low activity impairs HDL, insulin sensitivity, and endothelial function, all of which heighten event risk in FH. Regular aerobic and resistance exercise can modestly improve lipids and vessel health even if LDL falls only slightly.
Risk prevention
You can’t prevent the genetic change behind familial hypercholesterolemia (FH), but you can lower lifetime LDL levels and cut the risk of early heart disease. The focus is early detection, steady treatment, and heart‑healthy routines that fit your life. Different people need different prevention strategies—there’s no single formula. Because early symptoms of familial hypercholesterolemia are uncommon, screening and regular follow-up are key.
Get fasting lipid panels on a schedule your clinician sets. Early and repeated testing helps track LDL levels and guides treatment for FH.
Work with a lipid clinic or cardiologist experienced in FH. They can tailor targets and testing to your age, sex, and family history.
Take statins and other LDL‑lowering medicines exactly as prescribed. Consistent use over years is what reduces artery plaque and heart attack risk in FH.
Choose plenty of vegetables, fruits, whole grains, beans, and fish while limiting saturated fats and trans fats. Adding soluble fiber and plant sterols can nudge LDL lower in FH.
Transmission
Familial hypercholesterolemia (FH) is inherited, not contagious—you can’t catch it from friends, coworkers, or a partner. Usually, if a parent has familial hypercholesterolemia, each child has a 1-in-2 (50%) chance of inheriting the gene change and the tendency toward very high LDL cholesterol. Rarely, a child receives gene changes from both parents, leading to a more severe form that starts earlier in life. Sometimes FH appears in a child for the first time because of a new genetic change, even when neither parent is known to have it. This pattern explains how familial hypercholesterolemia is inherited and helps guide testing of relatives.
When to test your genes
Consider genetic testing if your LDL cholesterol is very high (often above 190 mg/dL or 4.9 mmol/L), if you have a strong family history of early heart disease, or if a close relative has confirmed familial hypercholesterolemia. Testing helps confirm diagnosis, guide treatment intensity, and cascade test relatives. Ask your clinician about referral to a lipid or genetics clinic.
Diagnosis
Familial hypercholesterolemia is usually identified by a pattern of very high LDL (“bad”) cholesterol from a young age, often with early heart disease in the family. Early and accurate diagnosis can help you plan ahead with confidence. Doctors combine what they see in the clinic with cholesterol measurements and, when available, a DNA test. The genetic diagnosis of familial hypercholesterolemia is confirmed by finding a change in a gene that controls LDL cholesterol levels.
Providers look for lifelong high LDL cholesterol and early heart disease in you or close relatives. This pattern separates familial hypercholesterolemia from more common, age‑related cholesterol issues.
Doctors check for firm, painless bumps over tendons (like the Achilles or knuckles) and a gray‑white ring around the iris at a young age. These findings, when present, support the diagnosis.
A blood test shows very high LDL cholesterol, often above 190 mg/dL (≥4.9 mmol/L) in adults and above 160 mg/dL (≥4.1 mmol/L) in children. Triglycerides are usually normal or only mildly raised.
A saliva or blood test looks for changes in genes that regulate LDL cholesterol. A positive result confirms familial hypercholesterolemia and can guide testing for relatives.
Stages of Familial hypercholesterolemia
Familial hypercholesterolemia does not have defined progression stages. It’s a lifelong inherited condition in which LDL (“bad”) cholesterol runs high from birth, so risk builds gradually rather than moving through set steps. People often have no early symptoms of familial hypercholesterolemia, so care usually starts with a cholesterol blood test and a look at family history. Different tests may be suggested to help confirm the diagnosis and monitor treatment, sometimes including a genetic test and scans or ultrasounds that look for early artery changes.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with familial hypercholesterolemia, the biggest question is how well cholesterol can be controlled over a lifetime and what that means for heart health. The condition raises LDL from birth, so without treatment the risk of early heart attack or stroke is much higher than average, sometimes in the 30s–50s for heterozygous FH and even in childhood or teens for the rare homozygous form. With modern therapy—high‑intensity statins, add‑on medicines like ezetimibe or PCSK9 inhibitors, and lifestyle support—many living with familial hypercholesterolemia lower LDL to safer ranges and substantially reduce that risk.
Prognosis refers to how a condition tends to change or stabilize over time. Early care can make a real difference, especially when treatment starts in childhood or soon after diagnosis; each decade of lower LDL is linked with fewer artery changes and better long‑term outcomes. Mortality today is driven mostly by cardiovascular disease, but aggressive LDL lowering and regular monitoring have narrowed the gap in life expectancy for people with heterozygous familial hypercholesterolemia. Those with homozygous familial hypercholesterolemia have a tougher course, yet newer options, including lipoprotein apheresis and newer medications, are improving survival.
Everyone’s journey looks a little different. Many people ask, “What does this mean for my future?”, and the practical answer is that staying on treatment, keeping appointments, and addressing other risks—blood pressure, smoking, weight, and diabetes—can shift the curve meaningfully in your favor. If you’re watching for early symptoms of familial hypercholesterolemia complications, remember that many heart problems are silent; routine checks like lipid panels, coronary calcium scoring in selected adults, and timely stress testing are more reliable than waiting for warning signs. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Day to day, the main concern is how very high LDL cholesterol affects the heart and blood vessels over time. Long-term effects vary widely, but without treatment the risk of heart attack, stroke, or artery disease tends to arrive earlier than average. There may be no early symptoms of familial hypercholesterolemia, so artery changes can build silently. Today’s treatments can lower risk substantially when used consistently.
In familial hypercholesterolemia, coronary arteries can narrow years earlier than in the general population. This raises the chances of chest pain and heart attack in early or mid‑adulthood.
Heart attacks may occur decades earlier than average, sometimes without much warning. Risk is higher when LDL has been very high since childhood.
Chest pressure or tightness with activity can appear at a younger age. Some slow down or avoid exertion because of discomfort or shortness of breath.
In familial hypercholesterolemia, cholesterol buildup can affect neck and brain arteries. This increases the chance of a transient ischemic attack or stroke.
How is it to live with Familial hypercholesterolemia?
Living with familial hypercholesterolemia often means managing something you can’t feel day to day, yet taking it seriously because high LDL cholesterol quietly raises the risk of early heart disease. Daily life usually centers on routine: medications taken consistently, heart‑healthy eating without extremes, regular exercise, and periodic blood tests, with checkups that start earlier than for most people. For many, there’s also a family ripple effect—parents, siblings, and children may need testing, and loved ones often become partners in lifestyle changes and encouragement. With good treatment and support, people can work, raise families, travel, and plan long term while keeping their heart risk in check.
Treatment and drugs
Familial hypercholesterolemia is treated with a combination of cholesterol-lowering medicines and heart-healthy habits to reduce the risk of early heart disease. Doctors often start with high-intensity statins, and may add ezetimibe or newer options like PCSK9 inhibitors if LDL cholesterol remains high; a doctor may adjust your dose to balance benefits and side effects. For severe cases, especially in homozygous FH, additional treatments such as lipoprotein apheresis or newer injectable/siRNA drugs may be considered by specialists. Alongside medical treatment, lifestyle choices play a role, including a diet low in saturated fat, regular physical activity, not smoking, and maintaining a healthy weight. Close monitoring with regular blood tests, screening family members, and long-term follow-up help tailor care over time.
Non-drug treatment
There are usually no early symptoms of familial hypercholesterolemia, so daily habits that lower LDL cholesterol become an important part of care. Alongside medicines, non-drug therapies can strengthen heart protection and support long-term health. These steps do not replace medication in FH, but they can add meaningful reductions in LDL and overall risk. The best plan is realistic, repeatable, and fits your life.
Choose mostly vegetables, fruits, beans, whole grains, nuts, and fish. Swap butter and processed meats for olive oil and lean proteins. Limit foods high in saturated fat and avoid trans fats.
Oats, barley, beans, lentils, and psyllium form a gel in the gut that traps some cholesterol. Regular intake can modestly lower LDL. Add fiber slowly and drink enough fluids to prevent bloating.
Fortified yogurts, spreads, or supplements with plant sterols can reduce LDL absorption. Use them daily with meals for best effect. Check labels to avoid extra sugars or unwanted additives.
If you live with excess weight, gradual loss can help improve LDL and triglycerides. Even a small, steady loss can benefit heart health. Seek support if weight changes feel challenging.
Your genes may have an impact on how drugs work for you
Medicines for familial hypercholesterolemia can work differently depending on your genes, which influence how your liver makes, carries, and clears LDL cholesterol. Genetic differences may change how well statins, ezetimibe, or PCSK9 inhibitors lower LDL or cause side effects.
Pharmacological treatments
Treatment for familial hypercholesterolemia focuses on medicines that sharply lower LDL (“bad”) cholesterol to cut heart and stroke risk. Even without early symptoms of familial hypercholesterolemia, therapy is started early and often combined. Not everyone responds to the same medication in the same way.
Atorvastatin or rosuvastatin are usually the first step and can lower LDL by 50% or more. They are taken daily; muscle aches and mild liver test changes can occur, and they should be avoided during pregnancy.
This add-on pill blocks cholesterol absorption in the gut and generally lowers LDL by about 15–25%. It is often paired with a statin or used alone if statins aren’t tolerated.
Alirocumab and evolocumab are self-injected antibodies that can drop LDL an additional ~50–60%. Doses are given every 2–4 weeks, and mild injection-site reactions are the most common side effect.
This small interfering RNA shot lowers LDL by roughly 50% by dialing down a liver protein that raises LDL. It is given on day 1, at 3 months, then every 6 months, which many find convenient.
Genetic influences
Familial hypercholesterolemia (FH) is usually inherited, not caused by diet or lifestyle alone. Most often, a single gene change hampers how the body clears LDL (“bad”) cholesterol, so high levels are present from birth. Family history is one of the strongest clues to a genetic influence. FH is usually passed in a way that gives each child of an affected parent about a 1 in 2 (50%) chance to inherit it. Rarely, a child inherits the gene change from both parents. This can cause extremely high cholesterol and complications very early in life, which is why early symptoms of familial hypercholesterolemia can appear in childhood in the severe form. Genetic testing can confirm the cause, guide testing for relatives, and—together with early treatment—helps lower lifelong heart risk for people with FH.
Is Familial hypercholesterolemia genetic?
Genetics are central in familial hypercholesterolemia: most cases result from inherited variants that raise LDL cholesterol from birth. A single altered gene can markedly increase lifelong heart risk. Family screening helps identify relatives who may also be affected.
Pharmacogenetics—how genetics influence drug effects
In familial hypercholesterolemia, the same inherited changes that push LDL (“bad”) cholesterol high also shape which cholesterol-lowering drugs are most likely to help and how strongly they work. Medicines like statins and ezetimibe rely on the LDL receptor pathway, so when that pathway is partly working they may still lower LDL, but if it’s barely working, add-on treatments that act differently—such as PCSK9 inhibitors or inclisiran—are often needed. Some people also carry a common change in a liver uptake gene (often called SLCO1B1) that raises the chance of muscle side effects with certain statins, especially simvastatin; in that case, doctors may choose a different statin or dose. Genetic testing can sometimes identify how your body responds to statins and newer agents, helping your clinician pick a safer, more effective plan. Response varies for many reasons; your FH subtype, other health conditions, and other medicines all guide decisions about dose, combinations, and the order of therapies. Knowing this ahead of time can set expectations for treatment options for familial hypercholesterolemia and may reduce trial and error on the way to safer LDL targets.
Interactions with other conditions
Living with familial hypercholesterolemia can change how other health issues affect your heart and blood vessels. When FH occurs alongside type 2 diabetes, obesity, or high blood pressure, plaque tends to build up in arteries faster, raising the risk of heart attack or stroke at a younger age. A condition may “exacerbate” (make worse) symptoms of another—an underactive thyroid or chronic kidney disease can push LDL cholesterol even higher, and inflammatory conditions like psoriasis or rheumatoid arthritis can add to vessel inflammation. If lipoprotein(a) is also elevated—another inherited cholesterol-related factor—overall risk can climb even when LDL is well controlled. Smoking compounds the damage and reduces the benefit you’d otherwise get from treatment. During pregnancy, FH needs extra planning because some cholesterol medicines are paused; careful monitoring of blood pressure and diabetes helps limit added strain on the heart. Because early symptoms of familial hypercholesterolemia are often silent, it’s worth discussing with your care team how each condition might influence the others and whether any adjustments to treatment are needed.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in which heart attacks seemed to strike early and often. A grandfather died in his 40s, an aunt needed bypass surgery before 50, cousins were told their cholesterol was “sky-high” as teenagers. Today we recognize many of these stories as signs of familial hypercholesterolemia, a condition that runs in families and drives very high LDL (“bad”) cholesterol from birth.
First described in the medical literature as clusters of premature heart disease, early reports focused on striking features doctors could see and measure: yellowish cholesterol deposits on tendons and eyelids, and LDL levels far above average. In the mid-20th century, careful family tracing showed a clear pattern—half of the children of an affected parent were also affected—pointing to a single-gene cause.
From these first observations, scientists began to uncover why cholesterol was building up. In the 1970s and 1980s, research revealed that many people with familial hypercholesterolemia have a faulty version of the LDL receptor, a protein on liver cells that normally pulls LDL out of the bloodstream. When that “dimmer switch” is turned down or not working, LDL lingers and climbs. Later work showed that changes in other genes, such as APOB and PCSK9, can lead to the same end result: very high LDL and early artery plaque.
Once considered rare, now recognized as one of the most common inherited metabolic conditions worldwide, familial hypercholesterolemia affects roughly 1 in 250 people. A much rarer form, when both copies of the gene are altered, can cause extremely high LDL in childhood and heart disease in the teens if untreated. Understandings have changed, but the central lesson has held steady: finding familial hypercholesterolemia early saves lives.
As statins, then ezetimibe, and more recently PCSK9 inhibitors and other therapies became available, the history of familial hypercholesterolemia shifted from describing tragedy to preventing it. Countries began piloting “cascade screening,” checking cholesterol and, when appropriate, genes across relatives once one person is diagnosed. This approach echoes what families had long noticed informally, but with organized follow-up and treatment.
In recent decades, knowledge has built on a long tradition of observation. We now know that people living with familial hypercholesterolemia can have very different journeys—some develop visible deposits, others do not; some have heart symptoms early, others much later—yet the shared thread is lifelong high LDL that benefits from early, steady treatment. Looking back helps explain why doctors today ask about relatives’ heart histories and recommend cholesterol checks in childhood when a parent is affected. Each historical step, from family stories to genetic discovery to effective medicines, has added to a clearer picture and a far better outlook.